Latest filing published 02 Jul 2010 for Anthera Pharmaceuticals Inc.
Insider track record
No signal scores available.
Ursula Fritsch: trading record in brief
Ursula Fritsch discloses dealings in Anthera Pharmaceuticals Inc to SEC (Form 4). The record holds 3 filings, for trades running from 4 March 2010 to 30 June 2010.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
On 2 July 2010 came the latest disclosure, a share grant in Anthera Pharmaceuticals Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Ursula Fritsch
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,000 sharesCommon StockSEC:0001209191-10-037150:0
- 7,500 sharesCommon StockSEC:0001209191-10-037150:1
- 17,523 sharesCommon StockSEC:0001209191-10-015103:0
3 of 3 declarations